vs
HECLA MINING CO（HL）とRevvity（RVTY）の財務データ比較。上の社名をクリックして会社を切り替えられます
Revvityの直近四半期売上が大きい（$772.1M vs $448.1M、HECLA MINING COの約1.7倍）。HECLA MINING COの純利益率が高く（30.0% vs 12.7%、差は17.3%）。HECLA MINING COの前年同期比売上増加率が高い（79.5% vs 5.9%）。Revvityの直近四半期フリーキャッシュフローが多い（$161.8M vs $134.7M）。過去8四半期でHECLA MINING COの売上複合成長率が高い（53.8% vs 9.0%）
ヘクラマイニングは米国を本拠地とする貴金属・卑金属の大手採掘企業で、主に銀、金、鉛、亜鉛を生産しています。鉱山は主に北米地域に分布し、宝飾品製造、工業生産、再生可能エネルギー分野などに原料を供給しており、米国有数の原生銀生産企業です。
レブィティ（Revvity, Inc.）は米国のライフサイエンス・診断事業を手がける企業で、製薬およびバイオテクノロジー業界を主な顧客とし、特に新たな細胞治療や遺伝子治療の開発に関連するサービス・製品を提供している。前身は多岐にわたる事業を展開してきた老舗企業パーキンエルマーである。
HL vs RVTY — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $448.1M | $772.1M |
| 純利益 | $134.4M | $98.4M |
| 粗利率 | 55.4% | — |
| 営業利益率 | 49.1% | 14.5% |
| 純利益率 | 30.0% | 12.7% |
| 売上前年比 | 79.5% | 5.9% |
| 純利益前年比 | 1027.2% | 3.9% |
| EPS（希薄化後） | $0.20 | $0.86 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $448.1M | $772.1M | ||
| Q3 25 | $409.5M | $698.9M | ||
| Q2 25 | $304.0M | $720.3M | ||
| Q1 25 | $261.3M | $664.8M | ||
| Q4 24 | $249.7M | $729.4M | ||
| Q3 24 | $245.1M | $684.0M | ||
| Q2 24 | $245.7M | $691.7M | ||
| Q1 24 | $189.5M | $649.9M |
| Q4 25 | $134.4M | $98.4M | ||
| Q3 25 | $100.7M | $46.7M | ||
| Q2 25 | $57.7M | $53.9M | ||
| Q1 25 | $28.9M | $42.2M | ||
| Q4 24 | $11.9M | $94.6M | ||
| Q3 24 | $1.8M | $94.4M | ||
| Q2 24 | $27.9M | $55.4M | ||
| Q1 24 | $-5.8M | $26.0M |
| Q4 25 | 55.4% | — | ||
| Q3 25 | 44.1% | 53.6% | ||
| Q2 25 | 39.3% | 54.5% | ||
| Q1 25 | 28.3% | 56.5% | ||
| Q4 24 | 27.4% | — | ||
| Q3 24 | 24.2% | 56.3% | ||
| Q2 24 | 20.9% | 55.7% | ||
| Q1 24 | 10.1% | 54.6% |
| Q4 25 | 49.1% | 14.5% | ||
| Q3 25 | 36.3% | 11.7% | ||
| Q2 25 | 30.8% | 12.6% | ||
| Q1 25 | 20.0% | 10.9% | ||
| Q4 24 | 15.3% | 16.3% | ||
| Q3 24 | 9.2% | 14.3% | ||
| Q2 24 | 16.5% | 12.4% | ||
| Q1 24 | 2.7% | 6.8% |
| Q4 25 | 30.0% | 12.7% | ||
| Q3 25 | 24.6% | 6.7% | ||
| Q2 25 | 19.0% | 7.5% | ||
| Q1 25 | 11.0% | 6.4% | ||
| Q4 24 | 4.8% | 13.0% | ||
| Q3 24 | 0.7% | 13.8% | ||
| Q2 24 | 11.3% | 8.0% | ||
| Q1 24 | -3.0% | 4.0% |
| Q4 25 | $0.20 | $0.86 | ||
| Q3 25 | $0.15 | $0.40 | ||
| Q2 25 | $0.09 | $0.46 | ||
| Q1 25 | $0.05 | $0.35 | ||
| Q4 24 | $0.03 | $0.77 | ||
| Q3 24 | $0.00 | $0.77 | ||
| Q2 24 | $0.04 | $0.45 | ||
| Q1 24 | $-0.01 | $0.21 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $301.2M | $919.9M |
| 総負債低いほど良い | — | — |
| 株主資本純資産 | $2.6B | $7.3B |
| 総資産 | $3.6B | $12.2B |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $301.2M | $919.9M | ||
| Q3 25 | $133.9M | $931.4M | ||
| Q2 25 | $296.6M | $991.8M | ||
| Q1 25 | $23.7M | $1.1B | ||
| Q4 24 | $26.9M | $1.2B | ||
| Q3 24 | $22.3M | $1.2B | ||
| Q2 24 | $24.6M | $2.0B | ||
| Q1 24 | $80.2M | $1.7B |
| Q4 25 | $2.6B | $7.3B | ||
| Q3 25 | $2.4B | $7.4B | ||
| Q2 25 | $2.3B | $7.6B | ||
| Q1 25 | $2.1B | $7.6B | ||
| Q4 24 | $2.0B | $7.7B | ||
| Q3 24 | $2.0B | $7.9B | ||
| Q2 24 | $2.0B | $7.9B | ||
| Q1 24 | $2.0B | $7.8B |
| Q4 25 | $3.6B | $12.2B | ||
| Q3 25 | $3.2B | $12.1B | ||
| Q2 25 | $3.3B | $12.4B | ||
| Q1 25 | $3.0B | $12.4B | ||
| Q4 24 | $3.0B | $12.4B | ||
| Q3 24 | $3.0B | $12.8B | ||
| Q2 24 | $2.9B | $13.4B | ||
| Q1 24 | $3.0B | $13.4B |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $217.1M | $182.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $134.7M | $161.8M |
| FCFマージンFCF / 売上 | 30.1% | 21.0% |
| 設備投資強度設備投資 / 売上 | 18.4% | 2.6% |
| キャッシュ転換率営業CF / 純利益 | 1.61× | 1.85× |
| 直近12ヶ月FCF直近4四半期 | $310.2M | $509.4M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $217.1M | $182.0M | ||
| Q3 25 | $148.0M | $138.5M | ||
| Q2 25 | $161.8M | $134.3M | ||
| Q1 25 | $35.7M | $128.2M | ||
| Q4 24 | $67.5M | $174.2M | ||
| Q3 24 | $55.0M | $147.9M | ||
| Q2 24 | $78.7M | $158.6M | ||
| Q1 24 | $17.1M | $147.6M |
| Q4 25 | $134.7M | $161.8M | ||
| Q3 25 | $90.1M | $120.0M | ||
| Q2 25 | $103.8M | $115.5M | ||
| Q1 25 | $-18.4M | $112.2M | ||
| Q4 24 | $6.7M | $149.8M | ||
| Q3 24 | $-690.0K | $125.6M | ||
| Q2 24 | $28.3M | $136.6M | ||
| Q1 24 | $-30.5M | $129.7M |
| Q4 25 | 30.1% | 21.0% | ||
| Q3 25 | 22.0% | 17.2% | ||
| Q2 25 | 34.1% | 16.0% | ||
| Q1 25 | -7.0% | 16.9% | ||
| Q4 24 | 2.7% | 20.5% | ||
| Q3 24 | -0.3% | 18.4% | ||
| Q2 24 | 11.5% | 19.7% | ||
| Q1 24 | -16.1% | 20.0% |
| Q4 25 | 18.4% | 2.6% | ||
| Q3 25 | 14.1% | 2.6% | ||
| Q2 25 | 19.1% | 2.6% | ||
| Q1 25 | 20.7% | 2.4% | ||
| Q4 24 | 24.3% | 3.4% | ||
| Q3 24 | 22.7% | 3.3% | ||
| Q2 24 | 20.5% | 3.2% | ||
| Q1 24 | 25.1% | 2.7% |
| Q4 25 | 1.61× | 1.85× | ||
| Q3 25 | 1.47× | 2.97× | ||
| Q2 25 | 2.80× | 2.49× | ||
| Q1 25 | 1.24× | 3.03× | ||
| Q4 24 | 5.66× | 1.84× | ||
| Q3 24 | 31.24× | 1.57× | ||
| Q2 24 | 2.82× | 2.87× | ||
| Q1 24 | — | 5.67× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
HL
| Silver Contracts | $258.5M | 58% |
| Gold | $129.2M | 29% |
| Zinc | $30.3M | 7% |
| Lead | $23.3M | 5% |
| Environmental Remediation Services | $9.2M | 2% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
